Differences in Breast Cancer Costs by Cancer Stage and Biomarker Subtype in New Zealand.

ABSTRACT:

Background

Breast cancer requires the greatest expenditure among all cancer types, and the costs vary by cancer stage and biomarker status.

Objective

This study aimed to examine the differences in public healthcare costs of breast cancer in New Zealand by stage and subtype.

Method

This study included patients diagnosed with invasive breast cancer between 1 July 2010 and 30 June 2018 and receiving services in public hospitals. These patients were identified from the National Breast Cancer Register and/or New Zealand Cancer Registry. Linking with the Pharmaceutical Collection, National Minimum Dataset, National Non-Admitted Patient Collection, and Mortality Collection, we estimated the median public healthcare costs of breast cancer by cancer stage and biomarker subtype

SUBMITTER: Lao C 

PROVIDER: S-EPMC9283551 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature